JPH0148913B2 - - Google Patents

Info

Publication number
JPH0148913B2
JPH0148913B2 JP56167303A JP16730381A JPH0148913B2 JP H0148913 B2 JPH0148913 B2 JP H0148913B2 JP 56167303 A JP56167303 A JP 56167303A JP 16730381 A JP16730381 A JP 16730381A JP H0148913 B2 JPH0148913 B2 JP H0148913B2
Authority
JP
Japan
Prior art keywords
group
propanol
phosphoric acid
mono
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56167303A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5798291A (en
Inventor
Bojiisu Erumaaru
Garu Rudei
Uaiman Gyuntaa
Bitsukaa Ue
Urufu Paaruke Urufu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of JPS5798291A publication Critical patent/JPS5798291A/ja
Publication of JPH0148913B2 publication Critical patent/JPH0148913B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C07F9/1651—Esters of thiophosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56167303A 1980-10-21 1981-10-21 Novel sulfur-containing phosphatide, manufacture and cancer medicine containing same Granted JPS5798291A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803039629 DE3039629A1 (de) 1980-10-21 1980-10-21 Neue schwefelhaltige phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
JPS5798291A JPS5798291A (en) 1982-06-18
JPH0148913B2 true JPH0148913B2 (enExample) 1989-10-20

Family

ID=6114827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56167303A Granted JPS5798291A (en) 1980-10-21 1981-10-21 Novel sulfur-containing phosphatide, manufacture and cancer medicine containing same

Country Status (2)

Country Link
JP (1) JPS5798291A (enExample)
DE (1) DE3039629A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047540A (en) 1987-12-17 1991-09-10 Shionogi & Co., Ltd. Lipid derivatives
DE69535758D1 (de) * 1994-08-29 2008-07-03 Univ Wake Forest Lipid-analoge zur behandlung von viralen infektionen
JP5040261B2 (ja) * 2006-09-28 2012-10-03 東洋紡績株式会社 （置換プロピルスルファニル）−アルキルアルコールの製造方法
EP2669287B1 (en) * 2010-12-24 2015-08-05 NOF Corporation Amino group-containing phosphorylcholine, and method for producing same

Also Published As

Publication number Publication date
JPS5798291A (en) 1982-06-18
DE3039629A1 (de) 1982-06-03

Similar Documents

Publication Publication Date Title
US4444766A (en) Sulfur-containing phospholipid compounds and therapeutic compositions
JP5536876B2 (ja) チアゾール誘導体及びｐ２ｙ１２受容体拮抗剤としてのそれらの使用
KR0147830B1 (ko) 페놀 치환된 젬-디포스포네이트 유도체, 이의 제조방법 및 제약학적 조성물
US4492659A (en) Phospholipid compound
US4562179A (en) Phospholipid derivatives, and pharmaceutical composition of the same
US7351844B2 (en) Bipolar trans carotenoid salts and their uses
CA2667211A1 (en) Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar)
US9604899B2 (en) Bipolar trans carotenoid salts and their uses
JPH0429676B2 (enExample)
JPH0259833B2 (enExample)
EP0970948B1 (en) Vitamin d 3? derivatives and remedies for inflammatory respiratory diseases prepared from the same
WO2014058330A2 (en) Process for preparation of mk-7 type of vitamin k2
US4710579A (en) 2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof
EP1723156B1 (en) Process for the preparation of pyridine derivatives
JP3009196B2 (ja) 抗ウイルス活性を有する薬剤、燐脂質誘導体及びその製造方法
Bhatia et al. Stereospecific synthesis of ether and thioether phospholipids. The use of L-glyceric acid as a chiral phospholipid precursor
JP2007522076A (ja) 双極性トランスカロテノイド塩及びそれらの使用
JPH0148913B2 (enExample)
DK145083B (da) Prostaglandin-analoge til anvendelse i midler til regulering af den reproduktive cyclos hos raske pattedyr
EP0106576B1 (en) Novel 5-membered cyclic compounds, process for the production thereof, and pharmaceutical use thereof
EP0043472B1 (en) 3-hydrocarbylthio-2-acyloxypropyl 2-trimethylammonioethyl phosphates, process for producing the same and pharmaceutical preparations containing the same
JPH0372076B2 (enExample)
KR960002727B1 (ko) 아즈렌 유도체, 트롬복산 a₂ 및 프로스타글랜딘 엔도퍼옥사이드 수용체 길항제및 그의 제법
JPH0617307B2 (ja) 抗腫瘍剤
EP0471856B1 (en) 15-deoxyprostaglandin derivative